18-Aug-2026 - The Globe and Mail BMO Capital Reaffirms Their Buy Rating on Gilead Sciences (GILD) In a report released yesterday, Evan Seigerman from BMO Capital reiterated a Buy rating on Gilead Sciences, with a price target of $174.00. The company’s shares closed yesterday at $138.92. Unlock ...
12-Aug-2026 - Yahoo Finance Why Gilead Sciences (GILD) Is Back In The Spotlight Gilead Sciences (GILD) is back in focus after announcing a collaboration with Nucleai that applies AI powered tissue analytics to its antibody drug conjugate programs, with the goal of speeding ...
Latest GILD Trades by Congress Members
6-MAY-2026 - Jared Moskowitz, FL (District 23) purchased between $1,001 and $15,000.
18-Aug-2026 - The Globe and Mail BMO Capital Reaffirms Their Buy Rating on Gilead Sciences (GILD) In a report released yesterday, Evan Seigerman from BMO Capital reiterated a Buy rating on Gilead Sciences, with a price target of $174.00. The company’s shares closed yesterday at $138.92. Unlock ...
12-Aug-2026 - Yahoo Finance Why Gilead Sciences (GILD) Is Back In The Spotlight Gilead Sciences (GILD) is back in focus after announcing a collaboration with Nucleai that applies AI powered tissue analytics to its antibody drug conjugate programs, with the goal of speeding ...
